Advanced Medical Solutions

Advanced Medical Solutions's reported carbon emissions

In 2025, Advanced Medical Solutions (AMS), headquartered in Great Britain, reported total carbon emissions of approximately 77,740,000 kg CO2e. This figure includes Scope 1 emissions of about 2,761,000 kg CO2e, Scope 2 emissions of approximately 5,013,000 kg CO2e, and significant Scope 3 emissions totalling around 69,966,000 kg CO2e. AMS has set ambitious climate commitments, aiming for a 42% absolute reduction in Scope 1 and 2 greenhouse gas emissions by 2030, using a 2021 baseline. Furthermore, the company is committed to achieving Net Zero emissions across all scopes by 2045. This long-term goal includes a specific target of reducing Scope 3 emissions by 30% in Category 12 (End-of-Life Treatment of Sold Products) by 2033, relative to a 2024 baseline. The company has made notable progress, having reduced energy expenses by 55% and greenhouse gas emissions by 40% in 2019. AMS's targets are aligned with the Science Based Targets initiative (SBTi), which validates their commitment to maintaining zero Scope 1 emissions through FY2030 and reducing Scope 2 emissions by 42% by FY2030 from a FY2023 base year. Overall, AMS is actively working towards significant emissions reductions and has established a clear pathway to meet its climate goals, reflecting its commitment to sustainability and environmental responsibility.